- Home
- PRTA vs PRO Comparison
PRTA vs PRO Comparison
Compare PRTA & PRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- PRO
- Stock Information
- Founded
- PRTA 2012
- PRO 1985
- Country
- PRTA Ireland
- PRO United States
- Employees
- PRTA N/A
- PRO N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- PRO EDP Services
- Sector
- PRTA Health Care
- PRO Technology
- Exchange
- PRTA Nasdaq
- PRO Nasdaq
- Market Cap
- PRTA 809.8M
- PRO 863.3M
- IPO Year
- PRTA N/A
- PRO 2007
- Fundamental
- Price
- PRTA $6.58
- PRO $16.53
- Analyst Decision
- PRTA Buy
- PRO Strong Buy
- Analyst Count
- PRTA 9
- PRO 10
- Target Price
- PRTA $27.67
- PRO $28.10
- AVG Volume (30 Days)
- PRTA 1.7M
- PRO 1.2M
- Earning Date
- PRTA 08-07-2025
- PRO 07-29-2025
- Dividend Yield
- PRTA N/A
- PRO N/A
- EPS Growth
- PRTA N/A
- PRO N/A
- EPS
- PRTA N/A
- PRO N/A
- Revenue
- PRTA $137,935,000.00
- PRO $336,006,000.00
- Revenue This Year
- PRTA N/A
- PRO $10.25
- Revenue Next Year
- PRTA $119.20
- PRO $10.46
- P/E Ratio
- PRTA N/A
- PRO N/A
- Revenue Growth
- PRTA 54.55
- PRO 7.97
- 52 Week Low
- PRTA $4.32
- PRO $13.61
- 52 Week High
- PRTA $25.42
- PRO $29.84
- Technical
- Relative Strength Index (RSI)
- PRTA 59.96
- PRO 52.43
- Support Level
- PRTA $5.96
- PRO $14.76
- Resistance Level
- PRTA $6.59
- PRO $20.28
- Average True Range (ATR)
- PRTA 0.38
- PRO 0.61
- MACD
- PRTA 0.15
- PRO 0.23
- Stochastic Oscillator
- PRTA 83.93
- PRO 96.58
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About PRO PROS Holdings Inc.
Pros Holdings Inc provides software solutions that optimize shopping and selling experiences for both business-to-business and business-to-consumer companies across industry verticals in more than nearly 80 countries. Its PROS Platform is designed to help businesses create, optimize and market available offers and handle orders through both first- and third-party digital channels. The firm generates key revenue form the United States of America, Germany, The rest of Europe, Africa, Asia-Pacific, and Middle East regions.